Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.

Little is known about the serologic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, or the IgM responses to Msg in HIV-positive and HIV-negative persons with respiratory symptoms.We conducted a prospective study of 550 patients, both HIV-positive (n =...

Full description

Bibliographic Details
Main Authors: Robert J Blount, Leah G Jarlsberg, Kieran R Daly, William Worodria, J Lucian Davis, Adithya Cattamanchi, Kpandja Djawe, Alfred Andama, Judith Koch, Peter D Walzer, Laurence Huang, International HIV-Associated Opportunistic Pneumonias (IHOP) Study
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3528778?pdf=render
id doaj-bd84722ab46443b4a301cb9df5766ec5
record_format Article
spelling doaj-bd84722ab46443b4a301cb9df5766ec52020-11-25T01:14:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5154510.1371/journal.pone.0051545Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.Robert J BlountLeah G JarlsbergKieran R DalyWilliam WorodriaJ Lucian DavisAdithya CattamanchiKpandja DjaweAlfred AndamaJudith KochPeter D WalzerLaurence HuangInternational HIV-Associated Opportunistic Pneumonias (IHOP) StudyLittle is known about the serologic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, or the IgM responses to Msg in HIV-positive and HIV-negative persons with respiratory symptoms.We conducted a prospective study of 550 patients, both HIV-positive (n = 467) and HIV-negative (n = 83), hospitalized with cough ≥2 weeks in Kampala, Uganda, to evaluate the association between HIV status, CD4 cell count, and other clinical predictors and antibody responses to P. jirovecii. We utilized ELISA to measure the IgM and IgG serologic responses to three overlapping recombinant fragments that span the P. jirovecii major surface glycoprotein: MsgA (amino terminus), MsgB (middle portion) and MsgC1 (carboxyl terminus), and to three variations of MsgC1 (MsgC3, MsgC8 and MsgC9).HIV-positive patients demonstrated significantly lower IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 compared to HIV-negative patients. We found the same pattern of low IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 among HIV-positive patients with a CD4 cell count <200 cells/µl compared to those with a CD4 cell count ≥200 cells/µl. HIV-positive patients on PCP prophylaxis had significantly lower IgM responses to MsgC3 and MsgC9, and lower IgG responses to MsgA, MsgC1, MsgC3, and MsgC8. In contrast, cigarette smoking was associated with increased IgM antibody responses to MsgC1 and MsgC3 but was not associated with IgG responses. We evaluated IgM and IgG as predictors of mortality. Lower IgM responses to MsgC3 and MsgC8 were both associated with increased in-hospital mortality.HIV infection and degree of immunosuppression are associated with reduced IgM responses to Msg. In addition, low IgM responses to MsgC3 and MsgC8 are associated with increased mortality.http://europepmc.org/articles/PMC3528778?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Robert J Blount
Leah G Jarlsberg
Kieran R Daly
William Worodria
J Lucian Davis
Adithya Cattamanchi
Kpandja Djawe
Alfred Andama
Judith Koch
Peter D Walzer
Laurence Huang
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
spellingShingle Robert J Blount
Leah G Jarlsberg
Kieran R Daly
William Worodria
J Lucian Davis
Adithya Cattamanchi
Kpandja Djawe
Alfred Andama
Judith Koch
Peter D Walzer
Laurence Huang
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
PLoS ONE
author_facet Robert J Blount
Leah G Jarlsberg
Kieran R Daly
William Worodria
J Lucian Davis
Adithya Cattamanchi
Kpandja Djawe
Alfred Andama
Judith Koch
Peter D Walzer
Laurence Huang
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
author_sort Robert J Blount
title Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
title_short Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
title_full Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
title_fullStr Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
title_full_unstemmed Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
title_sort serologic responses to recombinant pneumocystis jirovecii major surface glycoprotein among ugandan patients with respiratory symptoms.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Little is known about the serologic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, or the IgM responses to Msg in HIV-positive and HIV-negative persons with respiratory symptoms.We conducted a prospective study of 550 patients, both HIV-positive (n = 467) and HIV-negative (n = 83), hospitalized with cough ≥2 weeks in Kampala, Uganda, to evaluate the association between HIV status, CD4 cell count, and other clinical predictors and antibody responses to P. jirovecii. We utilized ELISA to measure the IgM and IgG serologic responses to three overlapping recombinant fragments that span the P. jirovecii major surface glycoprotein: MsgA (amino terminus), MsgB (middle portion) and MsgC1 (carboxyl terminus), and to three variations of MsgC1 (MsgC3, MsgC8 and MsgC9).HIV-positive patients demonstrated significantly lower IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 compared to HIV-negative patients. We found the same pattern of low IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 among HIV-positive patients with a CD4 cell count <200 cells/µl compared to those with a CD4 cell count ≥200 cells/µl. HIV-positive patients on PCP prophylaxis had significantly lower IgM responses to MsgC3 and MsgC9, and lower IgG responses to MsgA, MsgC1, MsgC3, and MsgC8. In contrast, cigarette smoking was associated with increased IgM antibody responses to MsgC1 and MsgC3 but was not associated with IgG responses. We evaluated IgM and IgG as predictors of mortality. Lower IgM responses to MsgC3 and MsgC8 were both associated with increased in-hospital mortality.HIV infection and degree of immunosuppression are associated with reduced IgM responses to Msg. In addition, low IgM responses to MsgC3 and MsgC8 are associated with increased mortality.
url http://europepmc.org/articles/PMC3528778?pdf=render
work_keys_str_mv AT robertjblount serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT leahgjarlsberg serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT kieranrdaly serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT williamworodria serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT jluciandavis serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT adithyacattamanchi serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT kpandjadjawe serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT alfredandama serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT judithkoch serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT peterdwalzer serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT laurencehuang serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
AT internationalhivassociatedopportunisticpneumoniasihopstudy serologicresponsestorecombinantpneumocystisjiroveciimajorsurfaceglycoproteinamongugandanpatientswithrespiratorysymptoms
_version_ 1725157440267223040